[Collateral effects of antiparkinsonian agents used in psychiatry].
D000547:Amantadine / Q000008:administration & dosage / Q000494:pharmacology; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology; D001286:Atropine Derivatives / Q000008:administration & dosage; D001590:Benztropine / Q000008:administration & dosage / Q000494:pharmacology; D001921:Brain / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D010640:Phenothiazines / Q000008:administration & dosage / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D012601:Scopolamine / Q000008:administration & dosage / Q000494:pharmacology
D000978:Antiparkinson Agents; D001286:Atropine Derivatives; D006634:Histamine H1 Antagonists; D010640:Phenothiazines; D001590:Benztropine; D001285:Atropine; D000547:Amantadine; D012601:Scopolamine
Efectos colaterales de los antiparkinsónicos usados en psiquiatría.